EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bioenergetic dysregulation in the basal ganglia and cerebellum of patients with premanifest and manifest Huntington's disease

Jannik Prasuhn, Maximilian G Ködderitzsch Mertins, Marta M Pokotylo, Joke-Lina Aßmann, Leon van Well, Julia Henkel, Jan Uter, Sebastian Loens, Alexander Münchau, Norbert Brüggemann

Neurobiology of Disease · 2026

DOI: 10.1016/j.nbd.2026.107480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2026. Verfasst von Jannik Prasuhn und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Movement Disorders, Department of Neurology, University-Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany; Institute of Ne…. Hauptthemen laut MEDLINE: Huntington Disease, Energy Metabolism, Basal Ganglia, Cerebellum. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder characterized by progressive motor, cognitive, and psychiatric symptoms. While early striatal degeneration is a well-established hallmark, emerging evidence points to broader network-level dysfunction involving the cerebellum and profound alterations in mitochondrial energy metabolism. However, in vivo studies systematically examining region-specific bioenergetic changes across disease stages are scarce. METHODS: Using 31Phosphorus magnetic resonance spectroscopic imaging (31P-MRSI), we quantified metabolite ratios and absolute concentrations of alpha adenosine triphosphate (ATP-α), phosphocreatine (PCr), and inorganic phosphate (Pi) in the anterior basal ganglia and cerebellum of 31 patients with HD (15 manifest, 16 premanifest) and 19 healthy controls without pathogenic HTT expansion (HC). RESULTS: Basal ganglia (ATP-α + PCr)/Pi and ATP-α/Pi were significantly elevated in premanifest (+10.0% and + 13.9%) and manifest patients (+16.4% and + 19.2%) compared to HC. High-energy phosphate (HEP) levels showed a stage-dependent pattern, with ATP-α PCr and ATP-α elevated in premanifest patients (+7.7% and + 3.9%) and reduced in manifest patients (-7.6% and -12.8%). All metabolite ratios showed no correlation with clinical scores but were inversely associated with subcortical atrophy, particularly in the caudate (rho = -0.327, p = 0.022), putamen (r = -0.372, p = 0.008), and globus pallidus (r = -0.327, p = 0.022). CONCLUSIONS: These findings reveal stage-dependent, region-specific alterations in HEP metabolism in patients with HD. The observed changes in the brain energy metabolism precede motor symptoms and are linked to structural atrophy rather than symptomatic burden, supporting the potential of 31P-MRSI as a sensitive in vivo biomarker of bioenergetic dysfunction in HD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseEnergy MetabolismBasal GangliaCerebellumHumansFemaleMaleAdultMagnetic Resonance SpectroscopyMiddle AgedPhosphocreatineAdenosine TriphosphateMagnetic Resonance Imaging

Stichwörter der Autor:innen

(31)phosphorus magnetic resonance spectroscopy imaging ((31)P-MRSI)Huntington's disease (HD)MetabolismMitochondrial dysfunctionNeuroimaging

Substanzen

PhosphocreatineAdenosine Triphosphate

Autor:innen und Institutionen

  • Section of Movement Disorders, Department of Neurology, University-Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany; Center for Brain,…
  • Section of Movement Disorders, Department of Neurology, University-Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany; Center for Brain, Behavior and Metabolism, University of Lübeck, Lübeck, Germany.
  • Institute of Systems Motor Science and Center for Rare Diseases, University of Lübeck, Lübeck, Germany.

Förderung

  • German Research Foundation

Zitieren

APA

Prasuhn, J., Ködderitzsch Mertins, M. G., Pokotylo, M. M., Aßmann, J. L., van Well, L., Henkel, J., Uter, J., Loens, S., Münchau, A., & Brüggemann, N. (2026). Bioenergetic dysregulation in the basal ganglia and cerebellum of patients with premanifest and manifest Huntington's disease. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2026.107480

Vancouver

Prasuhn J, Ködderitzsch Mertins MG, Pokotylo MM, Aßmann JL, van Well L, Henkel J, et al. Bioenergetic dysregulation in the basal ganglia and cerebellum of patients with premanifest and manifest Huntington's disease. Neurobiology of Disease. 2026. doi:10.1016/j.nbd.2026.107480

BibTeX
@article{Prasuhn2026,
  author = {Prasuhn, Jannik and Ködderitzsch Mertins, Maximilian G and Pokotylo, Marta M and Aßmann, Joke-Lina and van Well, Leon and Henkel, Julia and Uter, Jan and Loens, Sebastian and Münchau, Alexander and Brüggemann, Norbert},
  title = {Bioenergetic dysregulation in the basal ganglia and cerebellum of patients with premanifest and manifest Huntington's disease},
  journal = {Neurobiology of Disease},
  year = {2026},
  doi = {10.1016/j.nbd.2026.107480}
}
Kostenlos starten →